InvestorsHub Logo
icon url

stevo51

06/04/09 8:45 AM

#12 RE: investor911 #10

sounds like some major revs to me..
icon url

The Rainmaker

06/08/09 4:45 PM

#33 RE: investor911 #10

I'm hoping they mention the sales projections in their filings going forward.....even if for some reason INSV doesn't make sales projections I'm hoping the big two can....
icon url

The Rainmaker

06/10/09 10:42 AM

#40 RE: investor911 #10

Added a few down here in the .42 range, now is the time to buy before more updates hit imho....
icon url

The Rainmaker

07/23/09 1:48 AM

#100 RE: investor911 #10

Here's the website Bausch & Lamb has set up for INSV's pink eye drops called Besivance.

http://www.besivance.com/
icon url

$heff

09/01/09 1:18 AM

#209 RE: investor911 #10

INSV (.37) breakthrough w/big Pharma..This is a key article w/Pfizer & Bausch & Lomb. It was a writeup in the Ocular Surgery News. It speaks to the fact that Pfizer is a key player in the opthalmology space and particularly with Bausch & Lomb. So much so that they are going to be expanding their sales force and putting big money into this opthalmology.
http://www.box.net/shared/emlql6jtxo

"The other major move by Pfizer, announced in March, is a plan to co-promote eye care products with Bausch & Lomb. The 5-year plan essentially doubles the sales force of the two companies while expanding their potential offerings."

Best, Sheff